Insight Molecular Diagnostics Inc
(IMDX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 12-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,196 | -2,780 | -1,369 | -4,980 | -3,490 |
| Depreciation Amortization | 213 | 142 | 72 | 280 | 270 |
| Accounts payable and accrued liabilities | 275 | -16 | -192 | N/A | N/A |
| Other Working Capital | 1,553 | 1,274 | 917 | 3,220 | 2,180 |
| Other Operating Activity | 621 | 232 | 408 | 320 | 330 |
| Operating Cash Flow | $-2,534 | $-1,148 | $-164 | $-1,160 | $-710 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -11 | -11 | -11 | -9 | -20 |
| Net Acquisitions | 44 | N/A | N/A | 1,320 | 0 |
| Other Investing Activity | 0 | 0 | 0 | 9 | 0 |
| Investing Cash Flow | $33 | $-11 | $-11 | $1,320 | $-20 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 11,654 | 3,300 | N/A | N/A | N/A |
| Financing Cash Flow | $11,654 | $3,300 | $N/A | $0 | $0 |
| Beginning Cash Position | 257 | 257 | 257 | 100 | 830 |
| End Cash Position | 9,410 | 2,398 | 82 | 250 | 100 |
| Net Cash Flow | $9,153 | $2,141 | $-175 | $150 | $-730 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,534 | -1,148 | -164 | -1,160 | -710 |
| Capital Expenditure | -11 | -11 | -11 | N/A | N/A |
| Free Cash Flow | -2,545 | -1,159 | -175 | -1,160 | -710 |